Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer [PDF]
BMC Cancer, 2023 Purpose To assess construct validity and responsiveness of the Expanded Prostate Cancer Index Composite Instrument (EPIC-26) relative to the Short-Form Six-Dimension (SF-6D) and Assessment of Quality of Life 6-Dimension (AQoL-6D) in patients following ...
Norma B. Bulamu +3 more
doaj +2 more sources
Properties of SF-6D when longitudinal data from 16,398 spine surgery procedures is applied to 9 national SF-6D value sets [PDF]
Acta Orthopaedica, 2021 Background and purpose — There are several national value sets for SF-6D. For studies conducted in countries without a country-specific value set the authors may use a value set from a neighboring or culturally similar county.
Anders Joelson +2 more
doaj +2 more sources
Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study [PDF]
Frontiers in Endocrinology, 2023 ObjectiveThere is limited evidence for mapping clinical tools to preference-based generic tools in the Chinese thyroid cancer patient population. The current study aims to map the FACT-H&N (Functional Assessment of Cancer Therapy-Head and Neck Cancer)
Qing Yang +4 more
doaj +2 more sources
Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China [PDF]
Health and Quality of Life Outcomes, 2023 Objective To develop a mapping algorithm for generating the Short Form Six-Dimension (SF-6D) utility score based on the Functional Assessment of Cancer Therapy-Lung (FACT-L) of lung cancer patients.
Qing Yang +3 more
doaj +2 more sources
SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degeneration. [PDF]
PLoS ONE, 2017 Economic evaluations in wet age-related macular degeneration (ARMD) is hampered as often utility values for solely one eye are used, mostly the better-seeing eye (BSE).
Martijn S Visser +4 more
doaj +13 more sources
Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal [PDF]
Health and Quality of Life Outcomes, 2021 Background Evidence of health utility changes in patients who suffer from longstanding health complaints attributed to dental amalgam fillings are limited.
Admassu N. Lamu +5 more
doaj +2 more sources
Comparing the Performance of the SF-6D and the EQ-5D in Different Patient Groups [PDF]
Acta Médica Portuguesa, 2014 Introduction: This research aims to explore the performance of the SF-6D and the EQ-5D in patients suffering from asthma, chronic obstructive pulmonary disease, cataracts, and rheumatoid arthritis.
Lara N. Ferreira +2 more
doaj +3 more sources
A comparative study of EQ-5D-5L and SF-6D scales based on patients receiving oral anticoagulant therapy [PDF]
Health and Quality of Life OutcomesObjective Oral anticoagulant therapy is widely used for the prevention and treatment of thromboembolic diseases, yet it imposes significant burdens on patients’ health-related quality of life (HRQoL).
Shujie Dong +7 more
doaj +2 more sources
Predictors of health state utility values using SF-6D for Chinese adult patients with β-thalassemia major [PDF]
Frontiers in Public Health, 2023 BackgroundPatients with β-thalassemia major (β-TM), predominantly adult patients, are associated with physical, mental, and social problems, that result in decreased quality of life (QoL).
Runqi Zhang +14 more
doaj +2 more sources
SF-6D utility scores of smokers and ex-smokers with or without respiratory symptoms attending primary care clinics [PDF]
Health and Quality of Life Outcomes, 2019 Introduction The aim of this paper is to find out generic preference-based Short-Form 6 Dimensions (SF-6D) utility scores of smokers and ex-smokers with varying cigarette exposure, with and without respiratory symptoms.
Sau-nga Fu +3 more
doaj +2 more sources